Patrick J. Casey

Last updated
Patrick J. Casey
Patrick J. Casey headshot.jpg
Born
Patrick J. Casey

NationalityAmerican
Alma mater Augustana University (B.A., 1978)
Brandeis University (Ph.D., 1986)
Awards Public Administration Medal (2020)
Scientific career
Fields Biochemistry
Pharmacology
Institutions Duke University School of Medicine
Duke-NUS Medical School

Patrick J. (Pat) Casey is a biochemist and molecular pharmacologist and is a James B. Duke Professor of Pharmacology and Cancer Biology at Duke University School of Medicine. In 2005, he relocated to Singapore to help found the Duke-NUS Medical School Singapore, where he served as its Senior Vice Dean of Research through July, 2023.

Contents

Early life and education

Casey grew up on a family farm near Mitchell, S. Dakota. He received a B.A. in Biology and Chemistry from Augustana College in Sioux Falls, SD in 1978. After three years working as an analytical chemist at the James Ford Bell Technical Center in Minneapolis, he entered the PhD program in Biochemistry at Brandeis University, receiving his degree in 1986. Casey did postdoctoral training from 1986-1990 at the University of Texas Southwestern Medical Center with Alfred G. Gilman.

Career

Casey joined the faculty at Duke University in 1990 as an Assistant Professor of Pharmacology and Cancer Biology and Biochemistry. [1] His primary areas of research are in the fields of lipid modifications of proteins and in G protein signaling in cancer. Casey was the founding director of the Duke Center for Chemical Biology, established to spearhead interdisciplinary research and training in the application of fundamental chemical principles to the study of biology and the basis of disease and therapies. Awards for his work include the Established Investigator Award from the American Heart Association in 1992 and the Amgen Award from the American Society of Biochemistry and Molecular Biology in 2000. Casey was elected a Fellow of the American Association for the Advancement of Science in 2012, and received the Distinguished Faculty Award from the Duke Medical Alumni Association in 2018.

Casey relocated to Singapore In 2005 to spearhead the development of the Duke-NUS Medical School. [2] As Senior Vice Dean of Research at Duke-NUS, he was the chief architect of the five Signature Research Programs at Duke-NUS: Cancer and Stem Cell Biology, Cardiovascular and Metabolic Disorders, Neuroscience and Behavioral Disorders, Emerging Infectious Diseases, and Health Services and Systems Research. Casey has also played multiple roles in the Singapore Biomedical Sciences Initiative, serving on advisory committees for the Agency for Science, Technology and Research (A*STAR), National Medical Research Council (NMRC) and National Research Foundation (NRF). In July, 2023, Casey stepped down as Senior Vice Dean of Research at Duke-NUS, while remaining on the faculty of that institution and Duke University School of Medicine as Professor and Senior Advisor. [3]

In recognition of his public sector service in Singapore, Casey was awarded the Public Administration Medal (Silver) at Singapore’s National Day ceremony in Aug. 2020. [4] [5] Casey was appointed to the Board of Directors of Legend Biotech in Dec. 2020. [6]

Casey has also been very involved in training the next generation of scientists and clinician-scientists. He has trained numerous PhD, MD/PhD students and research fellows in his own lab, and has been involved in the development of several training programs. Casey was a founding member, and served as Director for 10 years, of Duke University’s Graduate Program in Molecular Cancer Biology, and led the development of a unique PhD Program in Integrated Biology and Medicine at Duke-NUS. [7]

Select publications

Related Research Articles

<span class="mw-page-title-main">Lipid-anchored protein</span> Membrane protein

Lipid-anchored proteins are proteins located on the surface of the cell membrane that are covalently attached to lipids embedded within the cell membrane. These proteins insert and assume a place in the bilayer structure of the membrane alongside the similar fatty acid tails. The lipid-anchored protein can be located on either side of the cell membrane. Thus, the lipid serves to anchor the protein to the cell membrane. They are a type of proteolipids.

<span class="mw-page-title-main">Prenylation</span> Addition of hydrophobic moieties to proteins or other biomolecules

Prenylation is the addition of hydrophobic molecules to a protein or a biomolecule. It is usually assumed that prenyl groups (3-methylbut-2-en-1-yl) facilitate attachment to cell membranes, similar to lipid anchors like the GPI anchor, though direct evidence of this has not been observed. Prenyl groups have been shown to be important for protein–protein binding through specialized prenyl-binding domains.

Farnesyltransferase is one of the three enzymes in the prenyltransferase group. Farnesyltransferase (FTase) adds a 15-carbon isoprenoid called a farnesyl group to proteins bearing a CaaX motif: a four-amino acid sequence at the carboxyl terminus of a protein. Farnesyltransferase's targets include members of the Ras superfamily of small GTP-binding proteins critical to cell cycle progression. For this reason, several FTase inhibitors are undergoing testing as anti-cancer agents. FTase inhibitors have shown efficacy as anti-parasitic agents, as well. FTase is also believed to play an important role in development of progeria and various forms of cancers.

<span class="mw-page-title-main">Gilbert Chu</span> American biochemist

Gilbert Chu is an American biochemist. He is a Professor of Medicine (Oncology) and Biochemistry at the Stanford Medical School.

<span class="mw-page-title-main">Angiogenin</span> Protein-coding gene in the species Homo sapiens

Angiogenin (ANG) also known as ribonuclease 5 is a small 123 amino acid protein that in humans is encoded by the ANG gene. Angiogenin is a potent stimulator of new blood vessels through the process of angiogenesis. Ang hydrolyzes cellular RNA, resulting in modulated levels of protein synthesis and interacts with DNA causing a promoter-like increase in the expression of rRNA. Ang is associated with cancer and neurological disease through angiogenesis and through activating gene expression that suppresses apoptosis.

<span class="mw-page-title-main">Lubert Stryer</span> American biochemist

Lubert Stryer is the Emeritus Mrs. George A. Winzer Professor of Cell Biology, at Stanford University School of Medicine. His research over more than four decades has been centered on the interplay of light and life. In 2007 he received the National Medal of Science from President Bush at a ceremony at the White House for elucidating the biochemical basis of signal amplification in vision, pioneering the development of high density microarrays for genetic analysis, and authoring the standard undergraduate biochemistry textbook, Biochemistry. It is now in its ninth edition and also edited by Jeremy Berg, John L. Tymoczko and Gregory J. Gatto, Jr.

Geranylgeranyltransferase type 1 or simply geranylgeranyltransferase is one of the three enzymes in the prenyltransferase group. In specific terms, Geranylgeranyltransferase adds a 20-carbon isoprenoid called a geranylgeranyl group to proteins bearing a CaaX motif: a four-amino acid sequence at the carboxyl terminal of a protein. Geranylgeranyltransferase inhibitors are being investigated as anti-cancer agents.

<span class="mw-page-title-main">Leukotriene C4 synthase</span> Protein-coding gene in the species Homo sapiens

Leukotriene C4 synthase is an enzyme that in humans is encoded by the LTC4S gene.

<span class="mw-page-title-main">FNTA</span> Protein-coding gene in the species Homo sapiens

Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha is an enzyme that in humans is encoded by the FNTA gene.

<span class="mw-page-title-main">GNAZ</span> Protein-coding gene in the species Homo sapiens

Guanine nucleotide-binding protein G(z) subunit alpha is a protein that in humans is encoded by the GNAZ gene.

<span class="mw-page-title-main">FNTB</span> Protein-coding gene in the species Homo sapiens

Protein farnesyltransferase subunit beta is an enzyme that in humans is encoded by the FNTB gene.

<span class="mw-page-title-main">CD248</span> Protein-coding gene in the species Homo sapiens

Endosialin is a protein that in humans is encoded by the CD248 gene.

<span class="mw-page-title-main">Avery August</span> Belizean-born American scientist (born 1964)

Avery August is a Belizean-born American scientist who is currently a professor of immunology and vice provost at Cornell University.

BOSC 23 is a human kidney cell line developed by Warren Pear in David Baltimore's lab that was derived from the 293T cell line. The main use of BOSC 23 is the production of recombinant retroviruses; it stably expresses Moloney murine leukemia virus proteins and when transiently transfected with recombinant retroviral vector DNA, produces high titers of infectious retroviral particles. The cell line does not produce detectable replication-competent virus, an important safety feature.

In biochemistry, S-Nitrosylation is the covalent attachment of a nitric oxide group to a cysteine thiol within a protein to form an S-nitrosothiol (SNO). S-nitrosylation has diverse regulatory roles in bacteria, yeast and plants and in all mammalian cells. It thus operates as a fundamental mechanism for cellular signaling across phylogeny and accounts for the large part of NO bioactivity.

Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute, the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.

<span class="mw-page-title-main">Warren Jackson Pledger</span>

Warren Jackson Pledger is a molecular cell biologist who is the Associate Director for Basic Sciences, Tampa General Hospital Cancer Institute and Professor, Department of Molecular Medicine, Morsani College of Medicine, USF Health in Tampa, Florida. He had been a Professor, Department of Surgery, University of Utah School of Medicine and a member of the Cell Response and Regulation Program, Huntsman Cancer Institute. He was the Associate Center Director for Basic Science at the Moffitt Cancer Center and Research Institute. He has held academic appointments and tenure at the University of North Carolina School of Medicine, Vanderbilt University School of Medicine and the University of South Florida College of Medicine.

Jacques Pouysségur is a French engineer and researcher. He was born on November 10, 1943 in Toulouse, Haute-Garonne.

<span class="mw-page-title-main">Sue Wickner</span> American biochemist and geneticist

Sue Hengren Wickner is an American biochemist and geneticist who is a distinguished investigator and the head of the DNA Molecular Biology section of the National Institutes of Health. Her laboratory is under the National Cancer Institute and is located in the Center for Cancer Research (NCI/CCR).

References

  1. "Patrick J Casey". Duke-NUS Medical School.
  2. Honey, Karen (November 2, 2009). "Life at the Duke of Singapore". The Journal of Clinical Investigation.
  3. "Duke-NUS appoints Prof Patrick Tan as Senior Vice-Dean for Research". EurekAlert!.
  4. "Recipients". Prime Minister's Office Singapore. 17 November 2018.
  5. "CSCB faculty recognised at the 2020 National Day Awards". Duke-NUS Medical School.
  6. "Legend Biotech Announces Appointment of Dr. Patrick Casey to the Board of Directors". Yahoo.com.
  7. Tan, Rebecca (August 12, 2015). "Asia's Scientific Trailblazers: Patrick Casey". Asian Scientist.